File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK) - Cell leukemia and lymphoma: An in vitro and in vivo preclinical evaluation [2]
  • Basic View
  • Metadata View
  • XML View
TitleProteasome inhibitor bortezomib-induced apoptosis in natural killer (NK) - Cell leukemia and lymphoma: An in vitro and in vivo preclinical evaluation [2]
 
AuthorsShen, L
Au, WY
Guo, T
Wong, KY
Wong, ML
Tsuchiyama, J
Yuen, PW
Kwong, YL
Liang, RH1
Srivastava, G1
 
Issue Date2007
 
PublisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/
 
CitationBlood, 2007, v. 110 n. 1, p. 469-470 [How to Cite?]
DOI: http://dx.doi.org/10.1182/blood-2007-02-072900
 
ISSN0006-4971
2012 Impact Factor: 9.06
2012 SCImago Journal Rankings: 4.553
 
DOIhttp://dx.doi.org/10.1182/blood-2007-02-072900
 
ISI Accession Number IDWOS:000247611000067
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorShen, L
 
dc.contributor.authorAu, WY
 
dc.contributor.authorGuo, T
 
dc.contributor.authorWong, KY
 
dc.contributor.authorWong, ML
 
dc.contributor.authorTsuchiyama, J
 
dc.contributor.authorYuen, PW
 
dc.contributor.authorKwong, YL
 
dc.contributor.authorLiang, RH
 
dc.contributor.authorSrivastava, G
 
dc.date.accessioned2012-05-29T06:13:25Z
 
dc.date.available2012-05-29T06:13:25Z
 
dc.date.issued2007
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationBlood, 2007, v. 110 n. 1, p. 469-470 [How to Cite?]
DOI: http://dx.doi.org/10.1182/blood-2007-02-072900
 
dc.identifier.doihttp://dx.doi.org/10.1182/blood-2007-02-072900
 
dc.identifier.epage470
 
dc.identifier.hkuros132778
 
dc.identifier.isiWOS:000247611000067
 
dc.identifier.issn0006-4971
2012 Impact Factor: 9.06
2012 SCImago Journal Rankings: 4.553
 
dc.identifier.issue1
 
dc.identifier.pmid17579189
 
dc.identifier.scopuseid_2-s2.0-34347400984
 
dc.identifier.spage469
 
dc.identifier.urihttp://hdl.handle.net/10722/148515
 
dc.identifier.volume110
 
dc.languageeng
 
dc.publisherAmerican Society of Hematology. The Journal's web site is located at http://bloodjournal.hematologylibrary.org/
 
dc.publisher.placeUnited States
 
dc.relation.ispartofBlood
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshApoptosis - Drug Effects
 
dc.subject.meshBoronic Acids - Therapeutic Use
 
dc.subject.meshCell Line, Tumor
 
dc.subject.meshDrug Screening Assays, Antitumor
 
dc.subject.meshHumans
 
dc.subject.meshKiller Cells, Natural - Drug Effects - Pathology
 
dc.subject.meshLeukemia, T-Cell - Drug Therapy - Pathology
 
dc.subject.meshLymphoma, T-Cell - Drug Therapy - Pathology
 
dc.subject.meshProtease Inhibitors - Therapeutic Use
 
dc.subject.meshPyrazines - Therapeutic Use
 
dc.subject.meshTumor Cells, Cultured
 
dc.titleProteasome inhibitor bortezomib-induced apoptosis in natural killer (NK) - Cell leukemia and lymphoma: An in vitro and in vivo preclinical evaluation [2]
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Shen, L</contributor.author>
<contributor.author>Au, WY</contributor.author>
<contributor.author>Guo, T</contributor.author>
<contributor.author>Wong, KY</contributor.author>
<contributor.author>Wong, ML</contributor.author>
<contributor.author>Tsuchiyama, J</contributor.author>
<contributor.author>Yuen, PW</contributor.author>
<contributor.author>Kwong, YL</contributor.author>
<contributor.author>Liang, RH</contributor.author>
<contributor.author>Srivastava, G</contributor.author>
<date.accessioned>2012-05-29T06:13:25Z</date.accessioned>
<date.available>2012-05-29T06:13:25Z</date.available>
<date.issued>2007</date.issued>
<identifier.citation>Blood, 2007, v. 110 n. 1, p. 469-470</identifier.citation>
<identifier.issn>0006-4971</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/148515</identifier.uri>
<language>eng</language>
<publisher>American Society of Hematology. The Journal&apos;s web site is located at http://bloodjournal.hematologylibrary.org/</publisher>
<relation.ispartof>Blood</relation.ispartof>
<subject.mesh>Apoptosis - Drug Effects</subject.mesh>
<subject.mesh>Boronic Acids - Therapeutic Use</subject.mesh>
<subject.mesh>Cell Line, Tumor</subject.mesh>
<subject.mesh>Drug Screening Assays, Antitumor</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>Killer Cells, Natural - Drug Effects - Pathology</subject.mesh>
<subject.mesh>Leukemia, T-Cell - Drug Therapy - Pathology</subject.mesh>
<subject.mesh>Lymphoma, T-Cell - Drug Therapy - Pathology</subject.mesh>
<subject.mesh>Protease Inhibitors - Therapeutic Use</subject.mesh>
<subject.mesh>Pyrazines - Therapeutic Use</subject.mesh>
<subject.mesh>Tumor Cells, Cultured</subject.mesh>
<title>Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK) - Cell leukemia and lymphoma: An in vitro and in vivo preclinical evaluation [2]</title>
<type>Article</type>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1182/blood-2007-02-072900</identifier.doi>
<identifier.pmid>17579189</identifier.pmid>
<identifier.scopus>eid_2-s2.0-34347400984</identifier.scopus>
<identifier.hkuros>132778</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-34347400984&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>110</identifier.volume>
<identifier.issue>1</identifier.issue>
<identifier.spage>469</identifier.spage>
<identifier.epage>470</identifier.epage>
<identifier.isi>WOS:000247611000067</identifier.isi>
<publisher.place>United States</publisher.place>
</item>
Author Affiliations
  1. The University of Hong Kong